Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EDIT | VYGR | RVNC | ||
| Company | Editas Medicine | Voyager Therapeut | Revance Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.52 | 8.50 | 4.05 | ||
| High | 5.69 | 8.56 | 4.05 | ||
| Low | 5.25 | 8.25 | 3.00 | ||
| Last | 5.32 | 8.44 | 3.32 | ||
| Change | -0.24 | unch | -0.97 | ||
| % Change | -4.32% | unch | -22.61% | ||
| Volume | 1,637,500 | 388,900 | 8,064,200 | ||
| 20-Day Average Volume | 1,879,515 | 493,600 | 2,136,100 | ||
| Previous Close | 5.56 | 8.44 | 4.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.51 | 8.06 | 3.79 | ||
| 20-Day Raw Stochastic | 29.71% | 64.13% | 21.69% | ||
| 20-Day Relative Strength | 38.29% | 49.72% | 36.94% | ||
| Weighted Alpha | -63.84 | -17.50 | -87.32 | ||
| Today's Opinion | 100% Sell | 16% Buy | 100% Sell | ||
| Previous Opinion | 88% Sell | 16% Buy | 80% Sell | ||
| Last Month's Opinion | 88% Sell | 64% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.17% since 05/03/24 | -4.20% since 05/03/24 | -15.95% since 05/03/24 | ||
| Low | 4.91 on 05/08/24 | 8.25 on 05/10/24 | 3.00 on 05/10/24 | ||
| High | 5.81 on 05/07/24 | 9.10 on 05/07/24 | 4.47 on 05/09/24 | ||
| 1-Month | |||||
| %Chg | -19.76% since 04/10/24 | -4.42% since 04/10/24 | -24.72% since 04/10/24 | ||
| Low | 4.91 on 05/08/24 | 7.26 on 04/25/24 | 3.00 on 05/10/24 | ||
| High | 6.77 on 04/11/24 | 9.10 on 05/07/24 | 4.53 on 04/11/24 | ||
| 3-Month | |||||
| %Chg | -28.59% since 02/09/24 | +11.05% since 02/09/24 | -43.82% since 02/09/24 | ||
| Low | 4.91 on 05/08/24 | 7.08 on 02/13/24 | 3.00 on 05/10/24 | ||
| High | 11.58 on 02/28/24 | 10.66 on 04/01/24 | 7.56 on 03/01/24 | ||
| 6-Month | |||||
| %Chg | -30.64% since 11/10/23 | +32.91% since 11/10/23 | -44.39% since 11/10/23 | ||
| Low | 4.91 on 05/08/24 | 6.06 on 11/13/23 | 3.00 on 05/10/24 | ||
| High | 11.69 on 12/06/23 | 11.72 on 01/02/24 | 9.74 on 01/02/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 457,227 | 459,035 | 447,087 | ||
| Shares Outstanding, K | 82,235 | 54,388 | 104,216 | ||
| Annual Sales | 78,120,000 | 250,010,000 | 234,040,000 | ||
| Annual Net Income | -153,220,000 | 132,330,000 | -323,990,000 | ||
| Last Quarter Sales | 60,050,000 | 90,060,000 | 69,800,000 | ||
| Last Quarter Net Income | -18,870,000 | 56,400,000 | -55,700,000 | ||
| 60-Month Beta | 2.09 | 0.98 | 1.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.76 on 05/08/24 | 1.25 on 02/28/24 | -0.58 on 05/09/24 | ||
| Latest Earnings Date | 05/08/24 | 05/13/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 2.77 | 0.00 | ||